Latest Form 4 insider transactions

Kendra D Miller, EVP & General Counsel of BJs RESTAURANTS INC, sold 13,195 shares of common stock on August 6, 2026.

Rick E Winningham, a Director of Jazz Pharmaceuticals plc, received 1,605 shares of common stock on August 5, 2026.

Mike Slessor, CEO and a Director of Formfactor Inc, reported multiple transactions in common stock on August 5, 2026.

Ted W Love, a Director of Jazz Pharmaceuticals plc, received 1,605 shares of common stock on August 5, 2026.

Donald Chad Carter, EVP, Correspondent Banking of Business First Bancshares, Inc., sold 1,875 shares of common stock on August 6, 2026 for $31.64 per share.

Andrew J Briggs, a Director of Farmers & Merchants Bancorp Inc, sold 6,000 shares of common stock on August 6, 2026.

Laura Hamill, a Director of Jazz Pharmaceuticals plc, received 1,605 shares of common stock on August 5, 2026.

Joaquin Duato, CEO and Chairman of the Board and a Director of Johnson & Johnson, sold 48,480 shares of common stock on August 5, 2026.

Aric Brendan Mckinnis, CFO, SVP Global Finance of Formfactor Inc, reported multiple transactions in common stock on August 5, 2026.

Patrick Kennedy, a Director of Jazz Pharmaceuticals plc, received 1,605 shares of common stock on August 5, 2026.

Michael Yelton, See Remarks below. of Eaton Corp plc, reported multiple transactions in common stock on August 6, 2026.

Patrick Murphy Gallagher, Chief Operating Officer of Arthur J. Gallagher & Co., reported a transaction in 23,800 shares of common stock on August 5, 2026.

Mark Douglas Smith, a Director of Jazz Pharmaceuticals plc, received 1,605 shares of common stock on August 5, 2026.

Gen IV Investment Opportunities, LLC and 3 others reported changes in beneficial ownership of Battalion Oil Corp common stock on August 7, 2026.

Elizabeth Forminard, EVP, Chief Legal Officer of Johnson & Johnson, sold 15,918 shares of common stock on August 6, 2026.

Jennifer E. Cook, a Director of Jazz Pharmaceuticals plc, received 1,605 shares of common stock on August 5, 2026.

Seamus Mulligan, a Director of Jazz Pharmaceuticals plc, received 1,605 shares of common stock on August 5, 2026.

Heather Ann Mcsharry, a Director of Jazz Pharmaceuticals plc, received 1,605 shares of common stock on August 5, 2026.

Mario A Harik, Chief Executive Officer and a Director of XPO, Inc., reported multiple transactions in common stock on August 7, 2026.

Punit Dhillon, Chief Executive Officer and a Director of Skye Bioscience, Inc., received 1,090,000 shares of common stock on August 7, 2026.

Patrick G Enright, a Director of Jazz Pharmaceuticals plc, received 1,605 shares of common stock on August 5, 2026.

Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA, sold 20,000 shares of common stock on August 5, 2026.

Ramesh Srinivasan, President & CEO and a Director of Agilysys Inc, sold 197,410 shares of common stock on August 5, 2026.

Eric Howard Baker, See Remarks, a Director and 10% owner of StubHub Holdings, Inc., reported a transaction in 18,130 shares of common stock on August 5, 2026.

Scott Michael Fitzgerald, Principal Accounting Officer of StubHub Holdings, Inc., reported a transaction in 18,150 shares of common stock on August 5, 2026.

Robert C. Abernethy Jr, a Director of Peoples Bancorp Of North Carolina Inc, sold 950 shares of common stock on August 7, 2026 for $42.33 per share.

Norbert G Riedel, a Director of Jazz Pharmaceuticals plc, received 1,605 shares of common stock on August 5, 2026.

Ramesh Srinivasan, President & CEO and a Director of Agilysys Inc, reported multiple transactions in common stock on June 18, 2026.

Rahul Khara, Chief Legal Officer of Disc Medicine, Inc., sold 5,000 shares of common stock on August 6, 2026 for $80.00 per share.

Lisa P. Britt, Sr. VP and Chief HR Officer of Thermo Fisher Scientific Inc., sold 5,850 shares of common stock on August 6, 2026 for $580.00 per share.